Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
Zak
Dmitry
D
Division of Hematology/Oncology, Drexel University College of Medicine, Philadelphia, PA 19102, USA. katashka@yahoo.com
Styler
Michael J
MJ
Rosenbluth
Jonathan Z
JZ
Brodsky
Isadore
I
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005266:Femoral Neoplasms / Q000188:drug therapy / Q000601:surgery; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000556:secondary; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D000077146:Irinotecan; D002955:Leucovorin / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary* / Q000601:surgery; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D012516:Osteosarcoma / Q000188:drug therapy* / Q000532:radiotherapy / Q000556:secondary*; D010166:Palliative Care; D016879:Salvage Therapy; D012535:Scalp; D012878:Skin Neoplasms / Q000188:drug therapy / Q000556:secondary; D013908:Thoracotomy; D000093542:Gemcitabine
D003841:Deoxycytidine; D005047:Etoposide; D000077146:Irinotecan; D004317:Doxorubicin; D002945:Cisplatin; D002955:Leucovorin; D007069:Ifosfamide; D002166:Camptothecin; D008727:Methotrexate; D000093542:Gemcitabine